NCT05096234View on ClinicalTrials.gov

18F-F-AraG PET Imaging to Evaluate Immunological Response to CAR T Cell Therapy in Lymphoma

PHASE1TerminatedINTERVENTIONAL
Enrollment

2

Participants

Timeline

Start Date

September 28, 2021

Primary Completion Date

May 9, 2022

Study Completion Date

October 9, 2023

Conditions
Non-Hodgkin's Lymphoma
Interventions
DRUG

[ 18F]F-AraG PET

Dose: 5 mCi (±10%) Mode of Administration: Intravenous (IV)

Trial Locations (1)

94305

Stanford University, School of Medicine, Stanford

Sponsors
All Listed Sponsors
collaborator

CellSight Technologies, Inc.

INDUSTRY

lead

Stanford University

OTHER